Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
Mark Kruzel, MD, MBA; serves as Associate Medical Director in Oncology at Quest Advanced Diagnostics.
Dr. Kruzel’s role bridges the gap from assay development to clinical utility and he provides guidance on the appropriate utilization of testing.
Dr. Kruzel has extensive research and industry experience ranging from managing an FDA trial site to commercializing a pharmaceutical compound for a start-up company. He has published numerous peer-reviewed journal articles as well as presented abstracts at both local and national conferences. Through his role at Quest, Dr. Kruzel has developed key opinion leader strategies which help Quest advance the field of precision medicine.